PrimeRFP SCOUT · Federal Contract Recompete Brief

36C24824A0038Incorporate FAR 52.222-90 in accordance WITH — Progenics Pharmaceuticals Inc

Progenics Pharmaceuticals Inc holds $95.0M across 149 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards in the incumbent pipeline.

248-Network Contract Office 8 (36C248)
Awarding office
Progenics Pharmaceuticals Inc
Recipient
Estimated value
6505
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Progenics Pharmaceuticals Inc — $90

Contract facts

Federal
Contract number36C24824A0038
Also listed as36C248-24-A-0038
Agency248-Network Contract Office 8 (36C248)
Awarding office248-Network Contract Office 8 (36C248)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentProgenics Pharmaceuticals Inc
UEIYLYKVRPCTCR3
PSC6505
Related solicitation36C24824Q1264

INCORPORATE FAR 52.222-90 IN ACCORDANCE WITH EXECUTIVE ORDER (E.O.) 14398, ADDRESSING DEI DISCRIMINATION BY FEDERAL CONTRACTORS, (91 FR 16147, MARCH 31, 2026) is a federal award for 248-Network Contract Office 8 (36C248) held by Progenics Pharmaceuticals Inc. Estimated value —. Related solicitation 36C24824Q1264.

INCORPORATE FAR 52.222-90 IN ACCORDANCE WITH EXECUTIVE ORDER (E.O.) 14398, ADDRESSING DEI DISCRIMINATION BY FEDERAL CONTRACTORS, (91 FR 16147, MARCH 31, 2026)

Incumbent footprint

Public record

Progenics Pharmaceuticals Inc$95.0M obligated across 149 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($95.0M) · all agencies
Department of Veterans Affairs (VA)$93.8M · 99%Department of Health and Human Services (HHS)$1.1M · 1%Department of Defense (DOD)$105K · 0%
Open full company profile

Related awards

Same incumbent
36C24625N1142
PYLARIFY F-18 INJECTIONS (336)
$1.2M
Aug 31, 2026
75N90025F00021
PIFLUFOLASTAT F-18 INJECTION DRUGS (PYLARIFY) FROM SOFIE CO.:1108959 [25-004297]
$611K
Sep 25, 2026
36C26126N0023
480 F18 PYLARIFY DOSES POP 1/1/2025 - 12/31/2025
$1.7M
Sep 26, 2026
75N90025F00003
PIFLUFOLASTAT F-18 INJECTION DRUGS (PYLARIFY) FROM SOFIE CO. [POTS 25-000073]
$2.1M
Sep 29, 2026
36C26122N0385
PYLARIFY (PIFLUFOLASTAT F18) NDC: 71258-0022-01
$4.5M
Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C24824A0038?

36C24824A0038 (Incorporate FAR 52.222-90 in accordance WITH) is a 248-Network Contract Office 8 (36C248) award with an estimated value of —, currently held by Progenics Pharmaceuticals Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C248-24-A-0038?

36C248-24-A-0038 is the dashed form of PIID 36C24824A0038 (Incorporate FAR 52.222-90 in accordance WITH), held by Progenics Pharmaceuticals Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C24824A0038?

248-Network Contract Office 8 (36C248) awarded 36C24824A0038 to Progenics Pharmaceuticals Inc.

Who is the incumbent on 36C24824A0038?

Progenics Pharmaceuticals Inc is the incumbent with $95.0M across 149 related awards in SCOUT’s public footprint.

When does Progenics Pharmaceuticals Inc’s 36C24824A0038 come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthly
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C24824A0038